Gastrinomas: advances in diagnosis and management. - Wikidata - wikimedia - TriplyDB

Gastrinomas: advances in diagnosis and management.

Gastrinomas: advances in diagnosis and management.

http://www.wikidata.org/entity/Q34358058

about

Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1.

P2860

Q33753449-C7C99A38-B88F-4349-88F8-C82143C44461 Q42424883-40583846-7938-455F-9B98-05F874B6417B

P2860

Gastrinomas: advances in diagnosis and management.

http://www.wikidata.org/entity/Q34358058

description

2004 nî lūn-bûn

@nan

2004 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Gastrinomas: advances in diagnosis and management.

@ast

Gastrinomas: advances in diagnosis and management.

@en

Gastrinomas: advances in diagnosis and management.

@nl

type

label

Gastrinomas: advances in diagnosis and management.

@ast

Gastrinomas: advances in diagnosis and management.

@en

Gastrinomas: advances in diagnosis and management.

@nl

prefLabel

Gastrinomas: advances in diagnosis and management.

@ast

Gastrinomas: advances in diagnosis and management.

@en

Gastrinomas: advances in diagnosis and management.

@nl

P1433

Q34358058-4E897FEC-DD51-4785-9417-CDF83506FCF7

P1476

Q34358058-6B87E357-D20B-413A-9EDA-858246F62D31

P2093

Q34358058-A2CDE4A6-537D-45CB-9F44-D8C8388FD650

P2860

Q34358058-166C60A0-B02D-4F18-8F32-7AFCC00FC8A5

Q34358058-51BF2BC9-86A7-4CD5-B229-80FB02A63AFA

Q34358058-5A0D61EA-2B0B-4B41-A3A3-F64D960132DF

Q34358058-61D0209B-349E-4CE4-BFD7-98C2E2A7974A

Q34358058-64360C65-CFFD-4E15-8188-E52D113D8BD4

Q34358058-669A1006-4B38-4784-B43E-F1BCB41B6F05

Q34358058-C352A708-41E1-4438-95AA-7F95616A5FFF

Q34358058-C4C8E57C-9174-40DE-B3FE-C187C34AE3BC

Q34358058-F1AF302E-AD5D-4B20-8717-1422B02CC72C

P304

Q34358058-4E0FB1E2-407F-4A29-8F63-157C9416652D

P31

Q34358058-2F106CF3-B896-4672-A3D7-C76FA7766E7F

P356

Q34358058-97A77B9B-A3BD-48EB-AB63-3D25581B1527

P478

Q34358058-D12ABCA0-F179-4821-AFE2-5C5199E8E814

P577

Q34358058-AC1D18F3-4B4B-4CAB-895E-79BD09083C0E

P698

Q34358058-BE7AAEED-C75A-4ADC-A431-E057E27E103F

P356

P1433

Neuroendocrinology

P1476

Gastrinomas: advances in diagnosis and management.

@en

P2093

Robert T Jensen

http://www.w3.org/2001/XMLSchema#string

P2860

Gastric secretion in Zollinger-Ellison syndrome. Correlation with clinical expression, tumor extent and role in diagnosis--a prospective NIH study of 235 patients and a review of 984 cases in the literature.

Molecular insights into gastrointestinal neuroendocrine tumours: importance and recent advances.

Somatostatin analogues in the treatment of endocrine tumors of the gastrointestinal tract.

Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1).

Surgery to cure the Zollinger-Ellison syndrome.

Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome?

Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.

Secretin and calcium provocative tests in the Zollinger-Ellison syndrome. A prospective study.

Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?

P304

23-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000080736

http://www.w3.org/2001/XMLSchema#string

P478

80 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15477712

http://www.w3.org/2001/XMLSchema#string